AAAAAA

   
Results: 1-8 |
Results: 8

Authors: ALTER HJ CONRYCANTILENA C MELPOLDER J TAN D VANRADEN M HERION D LAU D HOOFNAGLE JH
Citation: Hj. Alter et al., HEPATITIS-C IN ASYMPTOMATIC BLOOD-DONORS, Hepatology, 26(3), 1997, pp. 29-33

Authors: CONRYCANTILENA C SHAKIL AO VANRADEN M MELPOLDER JC KLEINER D HOOFNAGLE J ALTER HJ GIBBLE J NASS C NESS P
Citation: C. Conrycantilena et al., SYMPTOMS AND LIVER HISTOLOGY IN BLOOD-DONORS WITH HEPATITIS-C VIRUS-INFECTION, Transfusion, 36(9), 1996, pp. 202-202

Authors: CONRYCANTILENA C VANRADEN M GIBBLE J MELPOLDER J SHAKIL AO VILADOMIU L CHEUNG L DIBISCEGLIE A HOOFNAGLE J SHIH JW KASLOW R NESS P ALTER HJ
Citation: C. Conrycantilena et al., ROUTES OF INFECTION, VIREMIA, AND LIVER-DISEASE IN BLOOD-DONORS FOUNDTO HAVE HEPATITIS-C VIRUS-INFECTION, The New England journal of medicine, 334(26), 1996, pp. 1691-1696

Authors: PALENICEK JP GRAHAM NMH HE YD HOOVER DA OISHI JS KINGSLEY L SAAH AJ ARMENIAN H FARZADEGAN H KASS N MARGOLICK J MCARTHUR J PALENICEK J TAYLOR E PHAIR JP CHMIEL JS COHEN B OGORMAN M MURPHY R VARIAKOJIS D WESCH J WOLINSKY S DETELS R VISSCHER B CHEN I DUDLEY J FAHEY J GIORGI J LEE M MARTINEZMAZA O MILLER E MORGENSTERN H NISHANIAN P TAYLOR J ZACK J RINALDO C BECKER J GUPTA P HO M ZUCCONI LS MUNOZ A BEATY T EPSTEIN L GALAI N HOOVER D JACOBSON LP KUO V MIENERT C NELSON K PIANTADOSI S SU S SCHRAGER L VERMUND S KASLOW R VANRADEN M OBRAMS I SEMINARA D
Citation: Jp. Palenicek et al., WEIGHT-LOSS PRIOR TO CLINICAL AIDS AS A PREDICTOR OF SURVIVAL, Journal of acquired immune deficiency syndromes and human retrovirology, 10(3), 1995, pp. 366-373

Authors: CONRYCANTILENA C VILAMIDOU L MELPOLDER JC VANRADEN M ALTER HJ
Citation: C. Conrycantilena et al., PORPHYRIA-CUTANEA-TARDA IN HEPATITIS-C VIRUS-INFECTED BLOOD-DONORS, Journal of the American Academy of Dermatology, 32(3), 1995, pp. 512-514

Authors: CONRYCANTILENA C MELPOLDER JC VANRADEN M ALTER HI
Citation: C. Conrycantilena et al., CHARACTERISTICS AND MOTIVATION OF ANTI-HCV POSITIVE BLOOD-DONORS ADMITTING INTRAVENOUS DRUG-USE (IVDU), Transfusion, 35(10), 1995, pp. 229-229

Authors: ZUCCONI SL JACOBSON LP SCHRAGER LK KASS NE LAVE JR CARSON CA MORGENSTERN H ARNO PS GRAHAM NMH SAAH AJ PALENICEK J ARMENIAN H FARZADEGAN H MARGOLICK J MACARTHUR J PHAIR JP CHMIEL J COHEN B OGORMAN M VARIAKOJIS D WESCH J WOLINSKY S DETELS R VISSCHER B CHEN I DUDLEY J FAHEY J GIORGI J LEE M MARTINEZMAZA O MILLER E NISHANIAN P TAYLOR J ZACK J RINALDO C KINGSLEY L BECKER J GUPTA P HO M MUNOZ A BEATY T EPSTEIN L GALAI N HOOVER D MEINERT C NELSON K PIANTADOSI S SU S SCHRAGER L VERMUND S KASLOW R VANRADEN M SEMINARA D
Citation: Sl. Zucconi et al., IMPACT OF IMMUNOSUPPRESSION ON HEALTH-CARE USE BY MEN IN THE MULTICENTER AIDS COHORT STUDY (MACS), Journal of acquired immune deficiency syndromes, 7(6), 1994, pp. 607-616

Authors: GROOTHUIS JR SIMOES EAF LEVIN MJ HALL CB LONG CE RODRIGUEZ WJ ARROBIO J MEISSNER HC FULTON DR WELLIVER RC TRISTRAM DA SIBER GR PRINCE GA VANRADEN M HEMMING VG
Citation: Jr. Groothuis et al., PROPHYLACTIC ADMINISTRATION OF RESPIRATORY SYNCYTIAL VIRUS IMMUNE GLOBULIN TO HIGH-RISK INFANTS AND YOUNG-CHILDREN, The New England journal of medicine, 329(21), 1993, pp. 1524-1530
Risultati: 1-8 |